Alltracel second-quarter revenue up 19% from prior-year period

By Lisa Kerner

Charlotte, N.C., July 6 - Alltracel Pharmaceuticals plc said its second-quarter revenue of €5.1 million was up 19% from the same quarter last year.

Total first-half 2006 revenues of €9.5 million increased 13% from the first half of 2005.

Strong re-order levels and contract wins in its wound care and oral care businesses drove year-over-year growth, the company said.

"We believe this level of growth will continue into the second half of the year following the clearing of the wound care regulatory hurdles in China and Japan as well as expected new business wins in Oralcare," chief executive officer Tony Richardson said in a company news release.

"We also saw significant breakthroughs in our cardiovascular health business in terms of positive trials and developments of key partnerships."

Alltracel is a medical technology company based in Dublin, Ireland.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.